Studies on mCRC have demonstrated that high TS levels are correlated with resistance to fluoropyrimidine,[23] while low expression of TS mRNA predicts favorable response to fluorouracil-based chemotherapy and long-term survival in CRC patients.[24]. This evidence concerns the gene TYMS and colorectal carcinoma.